[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341414-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341414-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","sphingosine-is-involved-in-paptp-induced-death-of-pancreas-cancer-cells-by-interfering-with-mitochondrial-functions","Sphingosine is involved in PAPTP-induced death of pancreas cancer cells by interfering with mitochondrial functions","","Pancreatic ductal adenocarcinoma is a frequent cancer with very poor prognosis. The study pharmacologically targets the mitochondrial potassium channel mitochondrial Kv1.3 to evaluate how sphingolipids and mutated KRAS shape Kv1.3-driven cell death. Inhibition of Kv1.3 by PAPTP increases sphingosine and mitochondrial superoxide in membranes, enhanced by KRAS mutation, and this is blocked by sh-RNA knockdown of Kv1.3 or by inhibiting sphingosine-1-phosphate phosphatase.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/sphingosine-is-involved-in-paptp-induced-death-of-pancreas-cancer-cells-by-interfering-with-mitochondrial-functions/341414/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/sphingosine-is-involved-in-paptp-induced-death-of-pancreas-cancer-cells-by-interfering-with-mitochondrial-functions/341414.png","ImageObject",300,407,{"name":42,"@type":43},"Noah","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the central molecular target in this study?","Question",{"text":63,"@type":64},"The study focuses on the mitochondrial potassium channel mitochondrial Kv1.3 and how its inhibition affects downstream sphingolipid signaling and mitochondrial function.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does PAPTP influence sphingosine levels and mitochondrial activity?",{"text":68,"@type":64},"Inhibiting Kv1.3 with PAPTP increases sphingosine and superoxide associated with mitochondria/membranes, and it triggers mitochondrial depolarization via sphingosine binding to cardiolipin.",{"name":70,"@type":61,"acceptedAnswer":71},"How is PAPTP-induced cell death affected by KRAS mutation and other interventions?",{"text":72,"@type":64},"The effects are enhanced by KRAS mutation, and PAPTP-driven sphingosine formation and cell death are prevented by Kv1.3 downregulation (sh-RNA) and by blocking sphingosine-1-phosphate phosphatase; in vivo, combined therapy prolongs survival in mice with metastatic pancreatic cancer.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341414,1790464807,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","Journal of Molecular Medicine (2024) 102:947–959 [https://doi.org/10.1007/s00109-024-02456-2](https://doi.org/10.1007/s00109-024-02456-2)  \nSphingosine is involved in PAPTP‑induced death of pancreas cancer cells by interfering with mitochondrial functions  \nSameer H. Patel1 · Gregory C. Wilson1 · Yuqing Wu1 · Simone Keitsch2 · Barbara Wilker2 · Andrea Mattarei3 · Syed A. Ahmad1 · Ildiko Szabo4 · Erich Gulbins2  \nReceived: 17 January 2024 / Revised: 2 May 2024 / Accepted: 13 May 2024 / Published online: 23 May 2024 © The Author(s) 2024  \nAbstract  \nPancreas ductal adenocarcinoma belongs to the most common cancers, but also to the tumors with the poorest prognosis. Here, we pharmacologically targeted a mitochondrial potassium channel, namely mitochondrial Kv1.3, and investigated the role of sphingolipids and mutated Kirsten Rat Sarcoma Virus (KRAS) in Kv1.3-mediated cell death. We demonstrate that inhibition of Kv1.3 using the Kv1.3-inhibitor PAPTP results in an increase of sphingosine and superoxide in membranes and/ or membranes associated with mitochondria, which is enhanced by KRAS mutation. The effect of PAPTP on sphingosine and mitochondrial superoxide formation as well as cell death is prevented by sh-RNA-mediated downregulation of Kv1.3 . Induction of sphingosine in human pancreas cancer cells by PAPTP is mediated by activation of sphingosine-1-phosphate phosphatase and prevented by an inhibitor of sphingosine-1-phosphate phosphatase. A rapid depolarization of isolated mitochondria is triggered by binding of sphingosine to cardiolipin, which is neutralized by addition of exogenous cardiolipin. The significance of these findings is indicated by treatment of mutated KRAS-harboring metastasized pancreas cancer with PAPTP in combination with ABC294640, a blocker of sphingosine kinases. This treatment results in increased formation ofsphingosine and death of pancreas cancer cells in vitro and, most importantly, prolongs in vivo survival of mice challenged with metastatic pancreas cancer.  \nKey messages  \n• Pancreatic ductal adenocarcinoma (PDAC) is a common tumor with poor prognosis.  \n• The mitochondrial Kv1 .3 ion channel blocker induced mitochondrial sphingosine.  \n• Sphingosine binds to cardiolipin thereby mediating mitochondrial depolarization.  \n• Sphingosine is formed by a PAPTP-mediated activation of S1P-Phosphatase.  \n• Inhibition of sphingosine-consumption amplifies PAPTP effects on PDAC in vivo.  \nKeywords Pancreas cancer · Sphingosine · Cytochrome C · Kv1.3 · Mitochondria  \nAbbreviations  \nKRAS Kirsten Rat Sarcoma Virus  \nPDAC Pancreatic ductal adenocarcinoma  \nS1P Sphingosine-1 phosphate  \nPTP Permeability transition pore  \n* Erich Gulbins [erich.gulbins@uk-essen.de](erich.gulbins@uk-essen.de)  \n1 Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH, USA  \n2 Institute of Molecular Biology, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45122 Essen, Germany  \nGly/Asp Glycine/aspartate  \nGly/Cys Glycine/cysteine  \nsi-RNA Small inhibitory RNA Tim23 Translocase of the inner membrane 23  \nH/S HEPES/saline  \n3 Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy  \n4 Department of Biology, CNR Institute of Neurosciences, University of Padua, Padua, Italy  \nROS Reactive oxygen species TMRM Tetramethylrhodamine  \nCy3 Cyanine 3  \nAPC Allophycocyanine  \nFITC Fluorescein isothiocyanate  \nIntroduction  \nPancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related death in the United States. Unfortunately, the majority of patients with pancreatic cancer are metastatic at the time of diagnosis or already developed early micrometastatic disease with seemingly localized disease. This is seen with systemic recurrences despite treatment with surgery alone. The cornerstone of treatment to reduce recurrences remains systemic chemotherapy. Despite incremental improvements in treatment outcomes, results remain ab","cbCaipnHQ7ENZW6f","https://ap.wps.com/l/cbCaipnHQ7ENZW6f","pdf",1005118,13,"English","# Abstract\n# Key messages\n# Keywords\n# Abbreviations\n# Introduction","[{\"question\":\"What is the central molecular target in this study?\",\"answer\":\"The study focuses on the mitochondrial potassium channel mitochondrial Kv1.3 and how its inhibition affects downstream sphingolipid signaling and mitochondrial function.\"},{\"question\":\"How does PAPTP influence sphingosine levels and mitochondrial activity?\",\"answer\":\"Inhibiting Kv1.3 with PAPTP increases sphingosine and superoxide associated with mitochondria/membranes, and it triggers mitochondrial depolarization via sphingosine binding to cardiolipin.\"},{\"question\":\"How is PAPTP-induced cell death affected by KRAS mutation and other interventions?\",\"answer\":\"The effects are enhanced by KRAS mutation, and PAPTP-driven sphingosine formation and cell death are prevented by Kv1.3 downregulation (sh-RNA) and by blocking sphingosine-1-phosphate phosphatase; in vivo, combined therapy prolongs survival in mice with metastatic pancreatic cancer.\"}]","Sphingosine is involved in PAPTP-induced death of pancreas cancer cells by interfering with mitochondrial functions | PDF",1790041805,33,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/81072888eea654eeaff4376172a1eee2.webp",983,1305,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4bcfeb037246d9f1d2c90bc55f98484a.webp",982,1304,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/092fc6d8607c3c112cd555581643b728.webp",981,1303,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/334f4004090fad9745ad67153f4dfa6d.webp",980,1301]